Displaying articles by keyword Ventricular assist device

ISSN 2304-7232

Use of mechanical circulatory support in acute circulatory collapse…

There are various indications for a mechanical circulatory support (MCS) devices implantation. We report a case of the use of…

Wavelet transform procedure as the basis for complete automatic…

The article aims at describing the basic principles of cardiometry – a fundamentally new scientific field which enables the accurate…

Standardization of the ECG on the basis of cardiac…

The article aims at describing the basic system criteria of the ECG interpretation on the basis of the cardiac cycle…

Criteria of identification of individual heart cycle phases on…

Criteria of identification of individual heart cycle phases according to an ECG curve are described in this paper.

Identification of non-HLA antibodies in ventricular assist device recipients

Published in No.3 November 2013

Recipients of ventricular assist devices (VADR) have a higher incidence to develop antibodies (Abs) against human leukocyte antigens (HLA). Non-HLA antibodies like major histocompatibility complex class I-related chain A (MICA) and autoantibodies against angiotensin type 1 receptor (AT1R) and endothelin receptor A (ETAR) are also implicated in the pathogenesis of acute rejection and allograft vasculopathy. We monitored non-HLA- and HLA-Abs in VADR up to one year after implantation.